Strategic analysis of the in vitro diagnostics market in Europe,


In vitro diagnostics market in Europe

According to a new report published by Allied Market Research, titled “Europe In Vitro Diagnostics Market: Global Opportunity Analysis and Industry Forecast, 2020-2027”, the European in vitro diagnostics (IVD) market was valued at $13,825 million in 2019 , and is expected to reach $18,647 million at a CAGR of 4.8% from 2020 to 2027. In vitro diagnostics (IVD) includes medical equipment, aces and reagents, which are used to diagnose a medical condition . In addition, these devices are used to analyze tissue samples and bodily fluids taken from the patient. Additionally, there are a variety of in vitro diagnostic instruments operating on a variety of techniques, such as immunodiagnostics, tissue diagnostics, hematology, and molecular diagnostics.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐏𝐃𝐅 𝐁𝐨𝐮𝐜𝐡𝐞𝐫:

COVID-19 impact analysis:
Europe observed social distancing through nationwide lockdowns during the COVID-19 pandemic. This has led to various changes in each industry, such as new challenges in supply chains, rising and falling demand for products, availability of resources, and others. Likewise, the in vitro diagnostics market in Europe has also been affected by the COVID-19 outbreak. Moreover, the impact has been positive or negative for different sectors of the in vitro diagnostics industry. For example, the impact of nationwide lockdowns in Europe has not been favorable for some of the in vitro diagnostic services. However, the sudden demand for new IVD products for COVID-19 testing has led key players to launch various types of test kits. Therefore, the new test kits have obtained the European Conformity Mark (CE) in Europe, which has ensured the safe availability of test kits.

A major factor contributing to Europe’s growth in the in vitro diagnostics market is the increase in the number of in vitro diagnostic tests, which has led to an increase in the incidence of acute and infectious diseases. Furthermore, the increase in the geriatric population, victims of immunological disorders, is another major factor in the growth of the market.

In vitro diagnostics are used to diagnose various medical conditions such as infectious diseases, cancer, heart disease, and kidney disorders. In addition, technical skills are required for the use and handling of in vitro diagnostics and, therefore, the equipment is used in specialized medical facilities for diagnosis. For example, IVD products are used in facilities such as independent laboratories, hospitals, and point-of-care.

𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲:

Germany is expected to be the European market leader in in vitro diagnostics over the forecast period, owing to the sharp increase in the prevalence of infectious diseases, which leads to an increase in the use of immunodiagnostics used in the diagnosis of Infectious diseases. In addition, other factors such as increasing use of rapid tests such as continuous glucose monitoring and flash glucose monitoring are also contributing to the growth of the German in vitro diagnostics market.

𝐊𝐞𝐲 𝐁𝐞𝐧𝐞𝐟𝐢𝐭𝐬:
• This report includes detailed quantitative analysis along with current and future trends of the Europe In Vitro Diagnostics market from 2019 to 2027 to identify existing opportunities along with strategic evaluation.
• Europe In Vitro Diagnostics Market forecast is studied from 2020 to 2027.
• Europe in vitro diagnostics market size and estimates are based on a comprehensive analysis of key industry developments.
• Qualitative analysis based on innovative products facilitates strategic business planning.
• Development strategies adopted by leading European In Vitro Diagnostics market players are solicited to understand the competitive scenario of the market.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐂𝐮𝐬𝐭𝐨𝐦𝐢𝐳𝐚𝐭𝐢𝐨𝐧

𝐊𝐞𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐏𝐥𝐚𝐲𝐞𝐫𝐬:
• Abbott Laboratories
• Becton, Dickinson and company
• Biomérieux Sa
• Bio-Rad Laboratories, Inc.
• Danaher Corporation (Beckman Coulter, Inc.)
• Hoffmann-La Roche AG.
• Qiagen SA
• Siemens AG (Siemens Healthineers)
• Sysmex Company
• Thermo Fisher Scientific, Inc.

𝐎𝐭𝐡𝐞𝐫 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬

3D cell culture market:

Molecular diagnostics market:

Neurovascular Devices Market:

David Correa
5933 NE Win Sivers Drive
205 Portland, OR 97220
United States
Toll Free: 1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
[email protected]
The Web:

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:
Allied Market Research (AMR) is a full-service market research and business consulting division of Allied Analytics LLP, based in Portland, Oregon. AMR provides global enterprises as well as medium and small businesses with unparalleled quality of “Market Research Reports” and “Business Intelligence Solutions”. AMR has a focused vision to provide business insights and advice to help its clients make strategic business decisions and achieve sustainable growth in their respective market area.

AMR introduces its premium subscription-based Avenue online library, designed specifically to provide a unique and cost-effective solution for businesses, investors and universities. With Avenue, subscribers can benefit from a comprehensive repository of reports on over 2,000 niche industries and over 12,000 company profiles. Additionally, users can get online access to quantitative and qualitative data in PDF and Excel formats, as well as analyst support, customization, and updated versions of reports.

This press release was published on openPR.

Source link

Comments are closed.